The Impact of High Costs on Drug Development and Small Patient Populations

This chapter explores the high costs associated with developing new drugs and its impact on pharmaceutical companies. It discusses the clinical trial process as the most expensive part and highlights the need for solutions to encourage investment in research and development for drugs that help small patient populations.